CLINICAL TRIALS PROFILE FOR DEXTROSE 5% AND LACTATED RINGER'S

All Clinical Trials for Dextrose 5% And Lactated Ringer's

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00113685 ↗	Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury	Completed	National Heart, Lung, and Blood Institute (NHLBI)	N/A	2003-04-01	The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
NCT00113685 ↗	Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury	Completed	University of Washington	N/A	2003-04-01	The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
NCT00181077 ↗	Hypertonic Saline Use in Preeclampsia	Completed	Johns Hopkins University	Phase 1	2003-06-01	To compare hypertonic saline to Lactated Ringer's solution and assess whether one speeds up the process of getting rid of extra body water faster in women with preeclampsia.
NCT00311519 ↗	A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects	Completed	Halozyme Therapeutics	Phase 4	2005-11-01	The purpose of this research study to test the effectiveness of a study medication to increase how fast a solution called lactated Ringer's is absorbed when put under the skin subcutaneously. The medication to be studied is an enzyme called hyaluronidase, and is a human recombinant form of the enzyme. The drug company name for this medication is Hylenex. Hylenex was currently an investigational medication at the initiation of the study, but received FDA approval during the study. An investigational medication is a medication or formulation of a medication that is not approved by the United States Food and Drug Administration for use in this country but may be used in studies such as this one.

Clinical Trial Conditions for Dextrose 5% And Lactated Ringer's

Condition Name

Condition Name for Dextrose 5% And Lactated Ringer's
Intervention	Trials
Anesthesia	5
Post-ERCP Acute Pancreatitis	4
Cesarean Section	4
Hypotension	4

Condition MeSH

Condition MeSH for Dextrose 5% And Lactated Ringer's
Intervention	Trials
Hypotension	16
Pancreatitis	11
Hemorrhage	10
Pain, Postoperative	8

Clinical Trial Locations for Dextrose 5% And Lactated Ringer's

Trials by Country

Trials by Country for Dextrose 5% And Lactated Ringer's
Location	Trials
Egypt	37
United States	33
China	12
Korea, Republic of	5
Brazil	4

Trials by US State

Trials by US State for Dextrose 5% And Lactated Ringer's
Location	Trials
Illinois	4
Pennsylvania	3
Connecticut	3
California	3
Minnesota	2

Clinical Trial Progress for Dextrose 5% And Lactated Ringer's

Clinical Trial Phase

Clinical Trial Phase for Dextrose 5% And Lactated Ringer's
Clinical Trial Phase	Trials
Phase 4	39
Phase 3	14
Phase 2/Phase 3	4

Clinical Trial Status

Clinical Trial Status for Dextrose 5% And Lactated Ringer's
Clinical Trial Phase	Trials
Completed	64
Not yet recruiting	29
Recruiting	26

Clinical Trial Sponsors for Dextrose 5% And Lactated Ringer's

Sponsor Name

Sponsor Name for Dextrose 5% And Lactated Ringer's
Sponsor	Trials
Ain Shams University	9
Cairo University	6
Mansoura University	5

Sponsor Type

Sponsor Type for Dextrose 5% And Lactated Ringer's
Sponsor	Trials
Other	214
Industry	17
NIH	2